ProfileGDS4718 / 1569095_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 48% 45% 52% 46% 51% 52% 51% 49% 47% 49% 46% 51% 47% 48% 48% 49% 46% 52% 49% 49% 47% 48% 48% 47% 49% 49% 48% 46% 53% 50% 51% 51% 49% 50% 46% 52% 49% 48% 46% 52% 49% 48% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4426149
GSM549102patient 115, normal, homogenized [OPG study]5.4138848
GSM549104patient 119, normal, homogenized [OPG study]5.2539345
GSM549108patient 138, normal, homogenized [OPG study]5.6460652
GSM549119patient 077, normal, homogenized [OPG study]5.3300846
GSM549133patient 032, cancer, homogenized [OPG study]5.4996751
GSM549139patient 042, cancer, homogenized [OPG study]5.6375952
GSM549099patient 107, normal, homogenized [OPG study]5.5650951
GSM549109patient 139, normal, homogenized [OPG study]5.4635749
GSM549110patient 046, normal, homogenized [OPG study]5.3339747
GSM549114patient 063, normal, homogenized [OPG study]5.3937149
GSM549122patient 082, normal, homogenized [OPG study]5.2985646
GSM549134patient 033, cancer, homogenized [OPG study]5.5229351
GSM549136patient 036, cancer, homogenized [OPG study]5.2858347
GSM549140patient 044, cancer, homogenized [OPG study]5.3885548
GSM549111patient 047, normal, homogenized [OPG study]5.3954348
GSM549113patient 057, normal, homogenized [OPG study]5.3937149
GSM549132patient 031, cancer, homogenized [OPG study]5.2773746
GSM549137patient 038, cancer, homogenized [OPG study]5.6422552
GSM549142patient 047, cancer, homogenized [OPG study]5.5595249
GSM549100patient 110, normal, homogenized [OPG study]5.4522649
GSM549107patient 135, normal, homogenized [OPG study]5.3307847
GSM549115patient 068, normal, homogenized [OPG study]5.3674848
GSM549116patient 072, normal, homogenized [OPG study]5.3925348
GSM549120patient 078, normal, homogenized [OPG study]5.3220947
GSM549131patient 030, cancer, homogenized [OPG study]5.410249
GSM549118patient 074, normal, homogenized [OPG study]5.4560249
GSM549129patient 027, cancer, homogenized [OPG study]5.4317748
GSM549123patient 088, normal, homogenized [OPG study]5.2544646
GSM549124patient 006, cancer, homogenized [OPG study]5.7265453
GSM549126patient 015, cancer, homogenized [OPG study]5.5097450
GSM549128patient 025, cancer, homogenized [OPG study]5.5386451
GSM549103patient 117, normal, homogenized [OPG study]5.5998551
GSM549117patient 073, normal, homogenized [OPG study]5.3873249
GSM549138patient 041, cancer, homogenized [OPG study]5.503350
GSM549141patient 045, cancer, homogenized [OPG study]5.2577146
GSM549130patient 028, cancer, homogenized [OPG study]5.6343152
GSM549101patient 111, normal, homogenized [OPG study]5.5148949
GSM549105patient 128, normal, homogenized [OPG study]5.4450748
GSM549106patient 134, normal, homogenized [OPG study]5.2433346
GSM549112patient 048, normal, homogenized [OPG study]5.6300152
GSM549125patient 011, cancer, homogenized [OPG study]5.4904749
GSM549127patient 024, cancer, homogenized [OPG study]5.4351248
GSM549135patient 035, cancer, homogenized [OPG study]5.4039949